New Research: 2 stocks to buy as Nifty50 heads towards 40,000
Here is the latest financial fact sheet of ALPA LAB. For more details, see the ALPA LAB quarterly results and ALPA LAB share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.5 |
No. of shares | m | 21.04 |
1 Week | % | -5.0 |
1 Month | % | -18.1 |
1 Year | % | 56.7 |
52 week H/L | Rs | 115.0/50.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ALPA LAB EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 42 | 29 | 49 | 109 | 90 | |
Low | Rs | 20 | 11 | 14 | 36 | 49 | |
Sales per share (Unadj.) | Rs | 37.1 | 40.9 | 46.4 | 53.4 | 44.2 | |
Earnings per share (Unadj.) | Rs | 0.5 | 0.9 | 3.4 | 6.7 | 6.0 | |
Diluted earnings per share | Rs | 0.5 | 0.9 | 3.4 | 6.7 | 6.0 | |
Cash flow per share (Unadj.) | Rs | 2.0 | 2.4 | 4.0 | 7.5 | 6.6 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 46.8 | 47.7 | 51.2 | 57.9 | 64.0 | |
Adj. book value per share | Rs | 46.8 | 47.7 | 51.2 | 57.9 | 64.0 | |
Shares outstanding (eoy) | m | 21.04 | 21.04 | 21.04 | 21.04 | 21.04 | |
Price / Sales ratio | x | 0.8 | 0.5 | 0.7 | 1.4 | 1.6 | |
Avg P/E ratio | x | 64.6 | 23.2 | 9.0 | 10.8 | 11.6 | |
P/CF ratio (eoy) | x | 15.8 | 8.6 | 7.7 | 9.7 | 10.5 | |
Price / Book Value ratio | x | 0.7 | 0.4 | 0.6 | 1.3 | 1.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 654 | 430 | 654 | 1,525 | 1,457 | |
Total wages/salary | Rs m | 120 | 118 | 117 | 119 | 122 |
ALPA LAB INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 780 | 860 | 976 | 1,123 | 930 | |
Other income | Rs m | 53 | 29 | 44 | 108 | 94 | |
Total revenues | Rs m | 833 | 889 | 1,020 | 1,230 | 1,023 | |
Gross profit | Rs m | 11 | 34 | 77 | 107 | 81 | |
Depreciation | Rs m | 31 | 32 | 12 | 17 | 13 | |
Interest | Rs m | 6 | 2 | 1 | 2 | 2 | |
Profit before tax | Rs m | 28 | 29 | 108 | 196 | 159 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 17 | 11 | 35 | 55 | 33 | |
Profit after tax | Rs m | 10 | 19 | 72 | 141 | 126 | |
Gross profit margin | % | 1.5 | 3.9 | 7.9 | 9.5 | 8.7 | |
Effective tax rate | % | 63.3 | 36.2 | 32.8 | 28.0 | 20.8 | |
Net profit margin | % | 1.3 | 2.2 | 7.4 | 12.6 | 13.5 |
ALPA LAB BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 941 | 955 | 1,211 | 1,380 | 1,491 | |
Current liabilities | Rs m | 223 | 208 | 325 | 288 | 296 | |
Net working cap to sales | % | 92.0 | 86.9 | 90.8 | 97.3 | 128.6 | |
Current ratio | x | 4.2 | 4.6 | 3.7 | 4.8 | 5.0 | |
Inventory Days | Days | 229 | 242 | 191 | 249 | 326 | |
Debtors Days | Days | 1,404 | 1,044 | 1,326 | 1,237 | 1,835 | |
Net fixed assets | Rs m | 270 | 250 | 193 | 172 | 181 | |
Share capital | Rs m | 210 | 210 | 210 | 210 | 210 | |
"Free" reserves | Rs m | 775 | 793 | 866 | 1,007 | 1,135 | |
Net worth | Rs m | 985 | 1,004 | 1,076 | 1,217 | 1,346 | |
Long term debt | Rs m | 4 | 2 | 0 | 21 | 8 | |
Total assets | Rs m | 1,210 | 1,204 | 1,404 | 1,552 | 1,673 | |
Interest coverage | x | 5.8 | 15.8 | 139.3 | 90.3 | 71.9 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.6 | 0.7 | 0.7 | 0.7 | 0.6 | |
Return on assets | % | 1.3 | 1.7 | 5.2 | 9.2 | 7.7 | |
Return on equity | % | 1.0 | 1.8 | 6.7 | 11.6 | 9.3 | |
Return on capital | % | 3.4 | 3.1 | 10.1 | 16.0 | 11.9 | |
Exports to sales | % | 34.6 | 37.8 | 46.4 | 49.5 | 43.4 | |
Imports to sales | % | 7.1 | 12.1 | 73.6 | 5.7 | 4.6 | |
Exports (fob) | Rs m | 270 | 325 | 453 | 555 | 403 | |
Imports (cif) | Rs m | 56 | 104 | 718 | 64 | 43 | |
Fx inflow | Rs m | 270 | 325 | 453 | 555 | 403 | |
Fx outflow | Rs m | 57 | 107 | 721 | 65 | 46 | |
Net fx | Rs m | 213 | 218 | -268 | 490 | 357 |
ALPA LAB CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -10 | 178 | -17 | 99 | 89 | |
From Investments | Rs m | -147 | -112 | 59 | -156 | 21 | |
From Financial Activity | Rs m | -48 | -13 | 2 | 54 | -38 | |
Net Cashflow | Rs m | -204 | 53 | 43 | -2 | 72 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Mahendra Singh Chawla | COMP SEC: Megha Neema | YEAR OF INC: 1988 | BSE CODE: 532878 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare ALPA LAB With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.